Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.6110
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
Sequana Medical NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| - | 0.11 | 0.71 | 0.92 | 0.37 | 0.96 | |
Revenue Growth (YoY) | - | -85.19% | -22.81% | 149.04% | -61.54% | -0.76% |
Cost of Revenue | - | 0.03 | 0.16 | 0.2 | 0.08 | 0.2 |
Gross Profit | - | 0.08 | 0.55 | 0.72 | 0.29 | 0.76 |
Selling, General & Admin | 8.09 | 7.37 | 8.74 | 8.93 | 7.18 | 6.74 |
Research & Development | 3.57 | 4.86 | 10.99 | 13.63 | 11 | 7.97 |
Other Operating Expenses | 5.55 | 6.07 | 9.68 | 6.26 | 4.73 | 3.83 |
Total Operating Expenses | 17.21 | 18.3 | 29.41 | 28.81 | 22.91 | 18.53 |
Operating Income | -17.21 | -18.22 | -28.86 | -28.09 | -22.61 | -17.77 |
Interest Income | 0.23 | 0.21 | 1.05 | 0.45 | 0.25 | 0.17 |
Interest Expense | -34.61 | -26.36 | -4.29 | -2.73 | -0.85 | -1.35 |
Total Non-Operating Income (Expense) | -34.38 | -26.15 | -3.24 | -2.28 | -0.61 | -1.18 |
Pretax Income | -51.59 | -44.37 | -32.1 | -30.38 | -23.22 | -18.95 |
Provision for Income Taxes | 0.26 | 0.28 | 0.47 | 0.39 | 0.39 | 0.16 |
Net Income | -51.85 | -44.65 | -32.56 | -30.76 | -23.62 | -19.11 |
Net Income to Common | -51.85 | -44.65 | -32.56 | -30.76 | -23.62 | -19.11 |
Shares Outstanding (Basic) | 47 | 37 | 27 | 23 | 18 | 15 |
Shares Outstanding (Diluted) | 47 | 37 | 27 | 23 | 18 | 15 |
Shares Change (YoY) | 54.42% | 37.26% | 17.59% | 25.02% | 18.96% | 24.51% |
EPS (Basic) | -1.23 | -1.22 | -1.22 | -1.35 | -1.30 | -1.25 |
EPS (Diluted) | -1.23 | -1.22 | -1.22 | -1.35 | -1.30 | -1.25 |
Free Cash Flow | -17.69 | -20.35 | -29.77 | -28.16 | -23.94 | -17.14 |
Free Cash Flow Per Share | -0.38 | -0.55 | -1.11 | -1.24 | -1.31 | -1.12 |
Gross Margin | - | 74.94% | 76.95% | 77.83% | 79.31% | 78.99% |
Operating Margin | - | -17273.00% | -4052.70% | -3044.86% | -6103.55% | -1844.85% |
Profit Margin | - | -42325.70% | -4572.42% | -3334.08% | -6373.84% | -1983.45% |
FCF Margin | - | -19292.20% | -4180.74% | -3051.80% | -6462.39% | -1779.67% |
EBITDA | -16.16 | -17.61 | -28.2 | -27.78 | -22.21 | -17.46 |
EBITDA Margin | - | -16689.90% | -3959.84% | -3011.09% | -5993.28% | -1813.03% |
EBIT | -17.21 | -18.22 | -28.86 | -28.09 | -22.61 | -17.77 |
EBIT Margin | - | -17273.00% | -4052.70% | -3044.86% | -6103.55% | -1844.85% |
Effective Tax Rate | -0.51% | -0.63% | -1.45% | -1.27% | -1.69% | -0.83% |